(Total Views: 69)
Posted On: 04/15/2024 10:11:02 AM
Post# of 26563
![Avatar](https://investorshangout.com/images/ProfileImages/411968592_59827_pY--nyLE_400x400.png)
$ONVO News Article - Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo https://marketwirenews.com/news-releases/orga...13973.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
My Twitter: WhyteStocks